scholarly journals Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration

2018 ◽  
Vol 29 (1) ◽  
pp. 63-74 ◽  
Author(s):  
Yuek Ling Chai ◽  
Joyce R. Chong ◽  
Jiaju Weng ◽  
David Howlett ◽  
Andrea Halsey ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cathepsin D ◽  
Neurofibrillary Degeneration

Alzheimer's disease-type neurofibrillary degeneration in verrucose dysplasias of the cerebral cortex

1995 ◽  
Vol 90 (4) ◽  
pp. 356-365 ◽  
Author(s):  
M. A. Mor�n ◽  
A. Probst ◽  
C. Navarro ◽  
P. G�mez-Ramos
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cerebral Cortex ◽  
Disease Type ◽  
Neurofibrillary Degeneration

P1-396: COGNITION AND NEUROFIBRILLARY DEGENERATION IN PATIENTS WITH AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

2006 ◽  
Vol 14 (7S_Part_8) ◽  
pp. P454-P454
Author(s):  
Minyoung Oh ◽  
Jungsu S.S. Oh ◽  
Seung Jun Oh ◽  
Sang Ju Lee ◽  
Jee Hoon Roh ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Neurofibrillary Degeneration

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease

2019 ◽  
Vol 129 ◽  
pp. 217-233 ◽  
Author(s):  
Nicolas Sergeant ◽  
Valérie Vingtdeux ◽  
Sabiha Eddarkaoui ◽  
Marion Gay ◽  
Caroline Evrard ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Animal Models ◽  
Amyloid Deposition ◽  
Neurofibrillary Degeneration

IC-P-024: A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer's disease mouse model

2015 ◽  
Vol 11 (7S_Part_1) ◽  
pp. P26-P27
Author(s):  
Jonatan A. Snir ◽  
Mojmir Suchy ◽  
Geron A. Bindseil ◽  
Blaine A. Chronik ◽  
Robert H.E. Hudson ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Positron Emission Tomography ◽  
Mouse Model ◽  
Contrast Agent ◽  
Cathepsin D ◽  
Emission Tomography ◽  
Positron Emission

O1-02-05: A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer's disease mouse model

2015 ◽  
Vol 11 (7S_Part_3) ◽  
pp. P128-P128
Author(s):  
Jonatan A. Snir ◽  
Mojmir Suchy ◽  
Geron A. Bindseil ◽  
Blaine A. Chronik ◽  
Robert H.E. Hudson ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Positron Emission Tomography ◽  
Mouse Model ◽  
Contrast Agent ◽  
Cathepsin D ◽  
Emission Tomography ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document